PGT Genetic Counselling From Asansol: What to Ask Before IVF Testing

PGT is sometimes marketed as a universal upgrade to IVF. A patient may instead have a specific inherited condition in the family, a chromosome rearrangement or age-related questions about embryo chromosome status. These situations require different tests and different counselling. Ask what clinical question the proposed PGT would answer. A genetic counsellor should review family history and prior test reports when a hereditary condition is suspected. Avoid buying embryo testing before the indication is clearly defined.

PGT-M is designed for specific monogenic conditions, PGT-SR addresses selected structural chromosome rearrangements and PGT-A examines selected chromosome-number abnormalities. None can be described as a complete guarantee of a healthy child. Test validity and relevance depend on the laboratory protocol and the couple’s circumstances. PGT-M may require assay preparation or relatives’ samples before IVF. The clinician should explain which result classes might arise and how they would affect decisions about embryo transfer.

Biopsy and genetic analysis can lead to non-informative, complex or uncertain findings. A result may change which embryo is considered for transfer, but benefits and limitations are not identical across patient groups. Ask whether the clinic recommends PGT-A routinely or because of a specific indication, and what evidence it expects to apply. Some embryos may not reach the stage needed for testing. A clinic must not promise that every IVF cycle yields a tested transferable embryo.

A result reported through PGT does not necessarily replace prenatal diagnostic or screening options during pregnancy. Patients should understand residual risk, technical limitations and the possible role of confirmatory testing. This conversation is best held before embryo creation rather than after a positive pregnancy test. The geneticist and fertility clinician must coordinate advice without equating “normal test result” with absence of every possible condition.

A remote records review may help identify the right counselling questions before travel, where such consultation is actually offered. Sample collection, embryo biopsy, embryology and embryo transfer require suitable accredited facilities. HomeIVF does not claim a genetic laboratory or partner site in Asansol in this article. Ask the chosen provider where every step will happen, whether any consents must be signed in person and which consultations can be completed securely online.

An itemized estimate should distinguish doctor consultation, genetic counselling, possible test design, IVF stimulation, retrieval, ICSI where indicated, biopsy, testing per embryo, storage and transfer. Some work may be charged even if no embryo is available for testing. Ask the laboratory how an inconclusive result is managed and which fees are refundable. Funding decisions should follow informed consent, not a promise of selecting the “best baby” or a guarantee of success.

• Is the concern single-gene, structural-chromosome or chromosome-number?
• What result categories and limitations will the test produce?
• What is billed when no embryo is eligible for testing?

Treat these as decisions, not a shopping list for additional tests. The answer should be linked to a documented finding, a possible alternative and a clear next action. If the evidence is inconclusive, ask whether further testing would actually change care or only add expense. Record who will review results and what could trigger earlier medical attention.

HomeIVF is a doctor-led, home-supported fertility and IVF care model that aims to reduce unnecessary clinic visits. For a patient considering care from Asansol, West Bengal, teleconsultation, selected home blood collection or supervised injection assistance could be considered only if the treating clinician agrees and HomeIVF independently confirms a qualified service at the actual address. None is promised here. Any needed pelvic ultrasound, insemination, egg retrieval, sperm or embryo laboratory work, genetic testing and embryo transfer remain facility-based. Patients should be told which actual facility performs each procedure, who reviews time-sensitive results and how urgent symptoms are handled. Convenience must never replace essential monitoring.

Request an itemized written estimate from the actual provider, separating doctor visits, tests, scans, medicines, procedures, laboratory work, cryostorage and possible later transfer. Ask which costs remain if a cycle changes or is cancelled. Keep records and consent documents in a secure folder before a second opinion. Do not rely on a website location page as evidence of a local partner, price or guaranteed number of visits.